Quick Navigation

Risk of Alzheimer’s Disease

Research analysis led by .
Reviewed by
Examine.com Team
Last Updated:

Summary of Risk of Alzheimer’s Disease

Primary Information, Benefits, Effects, and Important Facts

Scientific Information on Risk of Alzheimer’s Disease

Tired of all the misinformation spread by supplement companies?

Learn what works, what's a waste, and how to achieve your health goals with our free supplement mini-course.

Are you looking for unbiased and trusted advice?

To quickly see all the supplements studied for any one of 500+ outcomes (like blood pressure, muscle gain, fat loss, or anxiety), become an Examine.com Member.

If you are looking for step-by-step directions on what works - and what's a waste - to help improve your health, then our Supplement Guides are exactly what you need.

Human Effect Matrix

The Human Effect Matrix looks at human studies (it excludes animal and in vitro studies) to tell you what supplements affect risk of alzheimer’s disease
Grade Level of Evidence
Robust research conducted with repeated double-blind clinical trials
Multiple studies where at least two are double-blind and placebo controlled
Single double-blind study or multiple cohort studies
Uncontrolled or observational studies only
Level of Evidence
? The amount of high quality evidence. The more evidence, the more we can trust the results.
Outcome Magnitude of effect
? The direction and size of the supplement's impact on each outcome. Some supplements can have an increasing effect, others have a decreasing effect, and others have no effect.
Consistency of research results
? Scientific research does not always agree. HIGH or VERY HIGH means that most of the scientific research agrees.
Notes
grade-c - Very High See 2 studies
Although ginkgo may have an acute therapeutic benefit, supplementation of ginkgo daily over the course of years in persons at risk for Alzheimer's does not appear to be too effective as a preventative supplement
grade-c - - See study
Vitamin E supplementation taken by otherwise healthy older adults does not appear to reduce the risk of developing Alzheimer's relative to placebo.